Brian K. Albrecht

3.5k total citations
21 papers, 947 citations indexed

About

Brian K. Albrecht is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Brian K. Albrecht has authored 21 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Brian K. Albrecht's work include Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (3 papers). Brian K. Albrecht is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (3 papers). Brian K. Albrecht collaborates with scholars based in United States and Germany. Brian K. Albrecht's co-authors include Robert M. Williams, Stephen K. Cox, Michael C. Hewitt, Natasha Cherman, Brian A. Lewis, Pamela Gehron Robey, Dinah S. Singer, Ballachanda N. Devaiah, Keiko Ozato and Robert J. Sims and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Organic Letters.

In The Last Decade

Brian K. Albrecht

21 papers receiving 910 citations

Peers

Countries citing papers authored by Brian K. Albrecht

Since Specialization

Citations

This map shows the geographic impact of Brian K. Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian K. Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian K. Albrecht more than expected).

Fields of papers citing papers by Brian K. Albrecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian K. Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian K. Albrecht. The network helps show where Brian K. Albrecht may publish in the future.

Co-authorship network of co-authors of Brian K. Albrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Brian K. Albrecht. A scholar is included among the top collaborators of Brian K. Albrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian K. Albrecht. Brian K. Albrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors 2020 ·ACS Medicinal Chemistry Letters ·Victor Gehling, John P. McGrath, Martin Duplessis, (unknown), (unknown), Rishi G. Vaswani, Alexandre Côté, Jacob I. Stuckey, (unknown), Richard Cummings, Srividya Balasubramanian, Priyadarshini Iyer, (unknown), Andrew C. Good, Brian K. Albrecht, Jean-Christophe Harmange, James E. Audia, Steven F. Bellon, Patrick Trojer, Julian Levell	18
2	Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation 2016 ·JCI Insight ·Kong Chen, Brian T. Campfield, Sally E. Wenzel, Jeremy P. McAleer, James L. Kreindler, Geoffrey Kurland, Radha Gopal, Ting Wang, Wei Chen, Taylor Eddens, Kathleen Quinn, Mike M. Myerburg, William Horne, José M. Lora, Brian K. Albrecht, Joseph M. Pilewski, Jay K. Kolls	18
3	Discovery, design, and synthesis of indole-based EZH2 inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Victor Gehling, Rishi G. Vaswani, Christopher G. Nasveschuk, Martin Duplessis, Priyadarshini Iyer, Srividya Balasubramanian, Feng Zhao, Andrew C. Good, Robert M. Campbell, Christina Lee, Les A. Dakin, Andrew S. Cook, Alexandre Gagnon, Jean-Christophe Harmange, James E. Audia, Richard Cummings, Emmanuel Normant, Patrick Trojer, Brian K. Albrecht	48
4	A Practical Synthesis of Indoles via a Pd-Catalyzed C–N Ring Formation 2014 ·Organic Letters ·Rishi G. Vaswani, Brian K. Albrecht, James E. Audia, Alexandre Côté, Les A. Dakin, Martin Duplessis, Victor Gehling, Jean-Christophe Harmange, Michael C. Hewitt, Yves Leblanc, Christopher G. Nasveschuk, Alexander M. Taylor	28
5	Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2 2014 ·ACS Medicinal Chemistry Letters ·Christopher G. Nasveschuk, Alexandre Gagnon, (unknown), Srividya Balasubramanian, Robert M. Campbell, Christina Lee, Feng Zhao, Louise Bergeron, Richard Cummings, Patrick Trojer, James E. Audia, Brian K. Albrecht, (unknown)	49
6	Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth 2013 ·Chemistry & Biology ·(unknown), Christopher G. Nasveschuk, Alexandre Gagnon, Eric Y. Chan, Péter Sandy, Jennifer Busby, Srividya Balasubramanian, Robert M. Campbell, Feng Zhao, Louise Bergeron, James E. Audia, Brian K. Albrecht, Jean-Christophe Harmange, Richard Cummings, Patrick Trojer	116
7	Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Christiane Bode, Alessandro A. Boezio, Brian K. Albrecht, Steven F. Bellon, Loren Berry, Martin A. Broome, Deborah M. Choquette, Isabelle Dussault, Richard T. Lewis, Min-Hwa Jasmine Lin, Karen Rex, Douglas A. Whittington, Yajing Yang, Jean-Christophe Harmange	16
8	Abstract LB-237: In vitro and in vivo characterization of CPI-267203, a potent Inhibitor of bromodomain-containing proteins 2012 ·Cancer Research ·Emmanuel Normant, Richard Cummings, Steven F. Bellon, Christopher M. Bailey, Brian K. Albrecht, Michael C. Hewitt, Eneida Pardo, Robert M. Campbell, Hari Jayaram, Florence Poy, Péter Sandy, Pranoti Gangurde	3
9	BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain 2012 ·Proceedings of the National Academy of Sciences ·Ballachanda N. Devaiah, Brian A. Lewis, Natasha Cherman, Michael C. Hewitt, Brian K. Albrecht, Pamela Gehron Robey, Keiko Ozato, Robert J. Sims, Dinah S. Singer	302
10	Synthesis and activity of substituted carbamates as potentiators of the α4β2 nicotinic acetylcholine receptor 2008 ·Bioorganic & Medicinal Chemistry Letters ·Stephanie K. Springer, Katrina S. Woodin, Virginia Berry, Alessandro A. Boezio, Lei Cao, Kristie Clarkin, Jean-Christophe Harmange, (unknown), Johannes Knop, Annika B. Malmberg, Jeff S. McDermott, Hung Q. Nguyen, Daniel J. Waldon, Brian K. Albrecht, Stefan McDonough	11
11	Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant α4β2 nicotinic acetylcholine receptor potentiators 2008 ·Bioorganic & Medicinal Chemistry Letters ·Brian K. Albrecht, Virginia Berry, Alessandro A. Boezio, Lei Cao, Kristie Clarkin, Wenhong Guo, Jean-Christophe Harmange, (unknown), Liyue Huang, (unknown), Johannes Knop, Annika B. Malmberg, Jeff S. McDermott, Hung Q. Nguyen, Stephanie K. Springer, Daniel J. Waldon, Katrina S. Woodin, Stefan McDonough	23
12	Identification of a Novel Glutathione Conjugate of Diclofenac by LTQOrbitrap 2008 ·Drug Metabolism Letters ·Yohannes Teffera, Daniel J. Waldon, Adria Colletti, Brian K. Albrecht, Zhiyang Zhao	9
13	Chemical Reactivity of Methoxy 4-O-Aryl Quinolines: Identification of Glutathione Displacement Products in Vitro and in Vivo 2008 ·Chemical Research in Toxicology ·Yohannes Teffera, Adria Colletti, (unknown), L. Steven Hollis, Brian K. Albrecht, Alessandro A. Boezio, Jingzhou Liu, Zhiyang Zhao	13
14	A concise, total synthesis of the TMC-95A/B proteasome inhibitors 2004 ·Proceedings of the National Academy of Sciences ·Brian K. Albrecht, Robert M. Williams	54
15	Asymmetric Synthesis of (+)-Hypusine 2001 ·Organic Letters ·Rajendra P. Jain, Brian K. Albrecht, Duane E. DeMong, Robert M. Williams	4
16	An Indexed Combinatorial Library: The Synthesis and Testing of Insect Repellents 2001 ·Journal of Chemical Education ·William H. Miles, Kathy A. Gelato, (unknown), (unknown), Brian K. Albrecht, Elaine Reynolds	6
17	Entry into the bi-aryl moiety of the TMC-95 proteasome inhibitors via the Stille protocol 2001 ·Tetrahedron Letters ·Brian K. Albrecht, Robert M. Williams	23
18	Effects of Echinostoma caproni infection on the phospholipid and sphingolipid content of the intestinal mucosa of ICR mice 1998 ·Journal of Helminthology ·Brian K. Albrecht, Bernard Fried, J. Sherma	6
19	Progress towards robotic exploration of extreme terrain 1992 ·Applied Intelligence ·Reid Simmons, Eric Krotkov, William Whittaker, Brian K. Albrecht, John Bares, (unknown), Regis Hoffman, (unknown), David Wettergreen	13
20	Procedures for Improving Pyrgeometer Performance 1977 ·Journal of applied meteorology ·Brian K. Albrecht, Stephen K. Cox	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact